Key result
The provided abstract contains only introductory background information and does not report any quantitative results comparing Samsung LABGEO PT10 and Bio-Rad Variant II Turbo.
Authors
Loading...
HbA1c monitoring supports glycemic assessment; leaves open need for outcome-linked validation of new assays.
Park et al. (2016) studied Diabetes Mellitus. Samsung LABGEO PT10 vs. Bio-Rad Variant II Turbo was evaluated. The provided abstract contains only introductory background information and does not report any quantitative results comparing Samsung LABGEO PT10 and Bio-Rad Variant II Turbo.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: